Generic GLP-1 Drugs Could Change the Weight-Loss Market—FDA Begins Review
The U.S. market for GLP-1 medicines continues to expand rapidly as demand for obesity and diabetes treatments grows. In another important …
Drug Manufacturing
FDA Plans to Simplify Drug Manufacturer Registration—Here’s Why It Matters
The U.S. Food and Drug Administration (FDA) has proposed a new rule that could simplify registration requirements for certain drug manufacturers …
Dr. Reddy’s Semaglutide Supply Delay: What It Means for the Global GLP-1 Market in 2026
The global race to expand access to GLP-1 medicines has reached another important milestone after Dr. Reddy’s Laboratories announced a temporary …